About N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide
N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide (PubChem CID 95791854) has the molecular formula C17H22N4O2
and a molecular weight of 314.39 g/mol. Its IUPAC name is N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide.
Analyze N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide?
The IUPAC name of N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide (CID 95791854) is N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide.
What is the SMILES notation for N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide?
The canonical SMILES for N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide is CC[C@@H](Cn1nnc2ccccc2c1=O)NC(=O)C1CCCC1.
What is the InChIKey of N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide?
The InChIKey is PQTWTEGEVYHFMN-ZDUSSCGKSA-N. The full InChI is InChI=1S/C17H22N4O2/c1-2-13(18-16(22)12-7-3-4-8-12)11-21-17(23)14-9-5-6-10-15(14)19-20-21/h5-6,9-10,12-13H,2-4,7-8,11H2,1H3,(H,18,22)/t13-/m0/s1.
What are the key properties of N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide?
N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide has a molecular weight of 314.39 g/mol, XLogP of 1.88, 5 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(2S)-1-(4-oxo-1,2,3-benzotriazin-3-yl)butan-2-yl]cyclopentanecarboxamide is sourced from PubChem (CID 95791854), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).